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Abstract
Background: There is a significant increase in survival for HIV-infected children who have early access to diagnosis
and treatment. The goal of this multi-country review was to examine when and where HIV-exposed infants and
children are being diagnosed, and whether the EID service is being maximally utilized to improve health outcomes
for HIV-exposed children.
Methods: In four countries across Africa and Asia existing documents and data were reviewed and key informant
interviews were conducted. EID testing data was gathered from the central testing laboratories and was then
complemented by health facility level data extraction which took place using a standardized and validated questionnaire
Results: In the four countries reviewed from 2006 to 2009 EID sample volumes rose dramatically to an average of
>100 samples per quarter in Cambodia and Senegal, >7,000 samples per quarter in Uganda, and >2,000 samples
per quarter in Namibia. Geographic coverage of sites also rapidly expanded to 525 sites in Uganda, 205 in Namibia,
48 in Senegal, and 26 in Cambodia in 2009. However, only a small proportion of testing was done at lower-level
health facilities: in Uganda Health Center IIs and IIIs comprised 47% of the EID collection sites, but only 11% of the
total tests, and in Namibia 15% of EID sites collected >93% of all samples. In all countries except for Namibia, more
than 50% of the EID testing was done after 2 months of age. Few sites had robust referral mechanisms between
EID and ART. In a sub-sample of children, we noted significant attrition of infants along the continuum of care post
testing. Only 22% (Senegal), 37% (Uganda), and 38% (Cambodia) of infants testing positive by PCR were
subsequently initiated onto treatment. In Namibia, which had almost universal EID coverage, more than 70% of
PCR-positive infants initiated ART in 2008.
Conclusions: While EID testing has expanded dramatically, a large proportion of PCR- positive infants are initiated
on treatment. As EID services continue to scale-up, more programmatic attention and support is needed to retain
HIV-exposed infants in care and ensure that those testing positive initiate treatment in a timely manner. Namibia’s
experience demonstrates that it is feasible for a rural, low-income country to achieve high national coverage of
infant testing and treatment.
Background
HIV infection is having an increasing impact on the
health of children, threatening to undermine hard-won
gains in child survival in countries with high HIV preva-
lence. Based upon the most recent global estimates, 2.3
million children younger than 15 years of age are living
with HIV [1], the vast majority of whom acquired HIV
from vertical transmission.M o r t a l i t yi sh i g ha m o n g
HIV-infected infants in the first months of life and with-
out access to life-saving drugs, including antiretroviral
therapy (ART) and co-trimoxazole prophylaxis (CPT),
30% of HIV positive children die in their first year of
life and approximately half do not survive until their
second birthday [2]. Importantly, there is a remarkable
increase in survival if HIV-infected children have access
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available to a very limited number of children in need
with only 15% of exposed infants in low and middle
income countries receiving a virologic test and 28% of
ART-eligible infants and children receiving ART [4].
One contributing factor to low coverage of ART in
infants is that diagnosing HIV in infants requires virolo-
gic testing, rather than simpler antibody-based rapid
tests that are used in adults. Early infant diagnosis (EID)
is done through polymerase chain reaction (PCR) testing
of dried blood spots that are collected at peripheral sites
and sent to central laboratories. WHO recommends that
all infants born from mothers who tested positive during
pregnancy should have a blood sample collected for EID
testing at four to six weeks of age [5]. This window has
been selected because EID testing has >95% HIV sensi-
tivity at this point, which also coincides with the period
when most national guidelines recommend the first set
of immunizations for infants. In addition, infants <18
months old who present with signs and symptoms of
HIV or infants presenting with unknown exposure sta-
t u ss h o u l db es c r e e n e df o re x p o s u r ea n di fe x p o s e d ,b e
rapidly given an HIV diagnostic test.
Though critically important for the survival of HIV
positive infants and the Universal Access objectives of
national programs, EID requires capacity, participation,
coordination, and management of multiple health struc-
tures as well as significant logistical, financial and
human investment. Due to increased investments by the
global community and national governments the num-
ber of laboratories providing EID services to the national
program increased dramatically in sub-Saharan Africa
from 2005 to 2009. However there remain concerns
regarding whether existing national programs are effec-
tive in identifying HIV-exposed and HIV-infected
infants and children and linking them in a timely man-
ner to required care and treatment. This comparative
descriptive analysis across four countries in Africa and
Asia reviews the early implementation of EID programs
as they are in the process of scaling up, with a specific
focus on examining when and where HIV-exposed
infants and children are being diagnosed and initiated
onto treatment.
Methods
Four countries- Cambodia, Namibia, Senegal and
Uganda - were selected to provide a broadly representa-
tive sample of HIV care in high and low HIV prevalence
countries in Asia and sub-Saharan Africa. All four min-
istries of health were solicited and agreed to the review
both for national program development and to contri-
bute to the global evidence base. In each country under
ministry leadership, a desk review of existing documents
and data and key informant interviews with key program
managers, laboratory staff, and implementing partners
were undertaken. Following this, EID testing data was
gathered from the central testing laboratories and then
complemented by health facility level data extraction
which took place using a standardized and validated
questionnaire. The focus of the paper is on the EID
laboratory testing data and health facility level data that
was extracted, but information on how the desk reviews
and key informant interviews were conducted is also
included below as reference for others who may want to
conduct a similar review.
Desk Review
The desk review included only available nationally
endorsed or commissioned documents, plans, and ana-
lyses of the data that were focused on EID, PMTCT,
and paediatric care and treatment. Documents where
EID, PMTCT, or paediatric HIV care and treatment
were not a primary focus or which were not endorsed
or commissioned by the respective Ministry of Health
were excluded. The rationale for these criteria was that
the objective was to conduct a focused review of
national EID programs, rather than the activities of spe-
cific partners or broader child health services. Docu-
ments reviewed included national policy documents,
national technical guidelines, relevant memos or circu-
lars, national forms and data collection tools used for
EID, national testing and procurement data, any existing
documentation of the EID system, national scale up
plans, and any analyses done to date of EID service.
The documents were provided by the Ministry of
Health in each country after a request from the UNI-
CEF country offices. This information was reviewed in
order to establish the history, policies and current status
of the EID program at a macro level. The desk review
began prior to the in-country visit and was supplemen-
t e db yd a t am a d ea v a i l a b l ei nt h ef i r s tt w od a y si n
country.
Key informant interviews
Key informants were defined as persons actively
involved in managing, supporting, or providing early
infant diagnosis services. This included program man-
agers in the ministries of health at national and district
level, technicians in the reference laboratory, health care
workers involved in EID and infant care at site level,
and partners involved in EID at an implementation
level. Feedback gathered included: (1) policy considera-
tions for EID (testing policy, paediatric ART guidelines,
user fees, platform selection, and program aspirations
for EID); (2) management of EID (planning, capacity,
financing supply chain, EID site expansion, logistics
management, and M&E); and (3) EID program imple-
mentation (infant identification approaches, logistics
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level coordination, and operational challenges.)
EID laboratory testing data and health facility level data
extraction
T h ef a c tt h a te a r l yi n f a n td i a g n o s i si sar e f e r e n c et e s t
allows for a significant amount of data to be gathered
centrally. The EID database at the central laboratory
was thus the lynchpin of the review and was used to
prepare analyses of testing volumes, age at testing over
time, and turn-around time analyses. The available data
was extracted from the central database which incorpo-
rated data from all laboratories performing EID in each
of the four countries. PMTCT/MIS data was gathered at
national and regional level.
For the health facility level data extraction, 18 to 25
EID collection sites per country were selected based on
health centre type, geography, partner participation and
maturity of the EID service. EID collection sites
reviewed contributed to variable proportions of total
EID tests completed by the national program in the
public sector ranging from 36% to 91% (Table 1). The
questionnaire, which is attached to this paper as Addi-
tional File 1, covered the EID continuum from early
identification of the HIV exposed infant (and missed
opportunities for identification) through to discharge of
the HIV negative baby with a confirmed status or initia-
tion on ART and allowed for the examination of service
availability and provision through the EID continuum
(Figure 1). Site level data was gathered from site EID
registers at different entry points, care and treatment
centres, and pharmacies, and was used to complete ana-
lyses of turn-around time, result return, and the impact
of the EID service. For purposes of this review, age at
EID testing was further stratified into three categories
(first EID test at < 2 months, at 2-6 months, and at > 6
months). Data collection was conducted between August
and December 2009. Data was entered in Excel and
analysed using simple frequency distributions. Since the
reviews were done using existing data from national
programs, the ministries of health and UNICEF staff did
not deem it necessary to seek IRB approval or to consult
ethical review committees in making this decision.
Results
EID sample volumes, geographic coverage, and utilization
In the four countries reviewed from 2006 to 2009 EID
sample volumes rose dramatically to >100 samples per
quarter in Cambodia and Senegal, >7,000 samples per
quarter in Uganda, and >2,000 samples per quarter in
Namibia. Figure 2 shows that quarterly volumes rose
steadily in Uganda, Senegal and Cambodia throughout
2008 and 2009. In Namibia, which had achieved almost
universal coverage of EID by 2008, volumes remained
steady from 2008 to 2009.
In 2009 in Uganda EID samples were sent to labora-
tories from over 525 sites across all 4 regions, including
all of the Regional Referral Hospitals, 143 of the 161
Health Centre (HC) IVs, 207 of the 955 HC IIIs, and 47
HC IIs. EID services were present at more than half of
the ~900 PMTCT sites nationwide and at many more
clinics than where paediatric ART was provided (234
sites). In Namibia, EID was available at 205 sites across
all 13 provinces, including the large majority of the 35
ART sites and more than 200 PMTCT sites. In Cambo-
dia, EID services were available at 26 sites across 16 of
23 provinces as well as in Phnom Penh and were avail-
able at the large majority of the 31 OI/ART Sites and
slightly less than half of the 69 Referral Hospitals. In
Senegal, EID services were offered at 48 sites across 12
of the 14 regions.
While expanded geographical coverage across the four
countries reviewed brought services closer to the
patient, it did not always translate into significantly
greater sample collection at lower-level facilities or more
even geographical distribution of sample collection. In
Uganda lower-level clinics (HC IIs and IIIs) comprised
47% of the EID collection sites nationally, but only 11%
of the total testing volume (Figure 3a). Data from Nami-
bia showed ~15% of the national EID sites collected
>93% of the total sample volume since the start of the
service. (Figure 3b)
Age at EID testing
The policies of all countries recommend testing begin-
ning at six weeks or as soon as possible thereafter. In all
countries the age of testing was recorded on the testing
form, but only in Namibia, did the laboratory coding
systematically record the reason for the testing to be
either “from PMTCT” or “symptomatic”, thus enabling
an accurate determination to be made regarding what
proportion of testing of infants known to be exposed
Table 1 Background characteristics of study populations
in 4 countries
12 3 4
1 6.5% 13.1% 0.5% 0.9%
2 4 13 14 10
32 0 2 5 2 1 1 8
48 1 1 1
52 1 1 1
6 17, 602 (36%) 14,148 (56%) 835 (91%) 335 (37%)
Vertical Axis-Countries: 1 - Uganda; 2 - Namibia; 3 - Cambodia; 4 - Senegal
Horizontal Axis - Characteristics: 1 - Adult HIV prevalence - 2009 estimate [7];
2 - No. of regions in each country covered by review; 3 - No. of health
facilities reviewed; 4 - No. of EID testing laboratories testing samples for the
national program 5 - No. of EID testing laboratories reviewed 6 - No. of
samples (proportion of total cumulative sample volume in public sector) at
reviewed sites.
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the first two months of life. In this case of 11,720 total
infants were coded as referred from PMTCT services
and 1,314 because of having symptoms suggestive of
HIV. The median age of testing among infants referred
from PMTCT services was approximately 2 months
over the life of the program, with a large proportion of
these infants being tested well after two months of age.
Although the specific reason behind referral for testing
in the other three countries was not known, among all
infants receiving EID, the proportion of tests that were
done in their first two months was less than 50% in
2009 in each country, although this proportion had
increased over time in all countries from 2007 to 2009
(Figure 4). The lowest ages at testing across all four
countries were seen at the large tertiary paediatric
focused centres known to have robust PMTCT and pae-
diatric services and with effective patient follow up sys-
tems in place.
Sample turn-around time
Sample turn-around time (TAT) was analysed from col-
lection at site to laboratory and averaged 1.38 days in
Namibia, 5.25 days in Cambodia, and 12.6 days in
Uganda over the life of the program, with wide variation
between sites. (In Senegal data was not available because
date of arrival at the laboratory was not documented in
EID database.) Namibia, with the shortest turnaround
time, used only one EID testing laboratory, but invested
in overnight transportation of all samples from 37 local
collection laboratories. Uganda with the most testing
laboratories actually had the longest sample transport
time. TAT for processing within laboratories averaged 9
days in Namibia, 18 days in Cambodia, and 3.33 weeks
in Uganda over the life of the program. In all countries
health facility registers did not systematically document
the date that the result arrived back at sites and there-
fore the total TAT from sample collection to result arri-
val at site could not be measured.
Models of service organization
There were two main models of service organization
observed at facility level for exposed infant care and EID
testing. The first is a centralized collection model where
services such as MCH, OPD and ART identify exposed
infants and refer infants to the site laboratory for EID sam-
ple collection. EID sample collection takes place in the site
laboratory and the parents of the infants are either told to
Figure 1 Infant Diagnosis Service Delivery Continuum.N o t e :A tt h et i m eo ft h er e v i e w s ,W H Og u i dance recommended that all children
under 12 months testing positive by PCR be initiated onto ART. 2010 WHO guidance now recommends that all children under 24 months of
age that test PCR-positive should be initiated onto treatment.
Figure 2 Samples tested for EID over time for the national
programs.
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or to the laboratory itself for test results. The second col-
lection model that a number of higher volume countries
or higher volume sites are implementing is the decentrali-
zation of EID sample collection beyond the site laboratory
to multiple points within the health care facility such as
the ANC, ART centre, OPD, and ward(s). In this model,
samples are collected by nurses or doctors within each ser-
vice. Infants have their EID samples collected, receive
exposed infant care, and receive their results all at the
same location
Referral to care and treatment
Across the sites reviewed, few had robust referral
mechanisms in place between testing and HIV care and
treatment. In a sub-sample of children in Uganda, Sene-
gal, and Cambodia for whom this data was available we
noted significant attrition of infants along the conti-
nuum of care post testing. The most complete data and
largest sample size was from Uganda (Figure 5). Overall,
only 22% (Senegal), 37% (Uganda), and 38% (Cambodia)
of infants that tested positive were ultimately initiated
on treatment. Among those who did receive their test
results and enrolled in HIV care but never initiated
ART, some were not initiated because they were: 1)
older than twelve months of age at enrolment and not
clinically or immunologically eligible to initiate ART; or
2) enrolled at <12 m prior to the guideline changes call-
ing for immediate treatment initiation for infants <12
months testing HIV positive. It is important to note,
however, that after WHO issued new recommendations
in 2008, Uganda issued a policy change for all infants to
be initiated on ART in June 2008, and Senegal and
Cambodia similarly changed their guidelines in 2009.
Namibia had adapted it guidelines in 2007 to call for
immediate ART for all infants even in advance of the
2008 WHO recommendations.
In Namibia, we examined the extent to which PCR-
positive infants who were enrolled in HIV care subse-
quently initiated ART and associated time delays. The
proportion of HIV-positive infants initiating ART
increased after the new guidelines and delays in time to
initiation correspondingly decreased (Figure 6), with
more than 70% of known PCR-positive infants initiating
ART in 2008 within 6 months of when they were
enrolled in HIV care.
         
Figure 3 Utilization of EID by level of health care delivery system. Top: Availability and uptake of EID by level of health care delivery system
in Uganda. Bottom: Number of samples from Hospitals vs. Health Centers in Namibia from 2006-2009.
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We report a dramatic increase in EID testing volumes
between 2006 and 2009 in four countries which repre-
sent a mix of high (Namibia, Uganda) and lower (Cam-
bodia, Senegal) HIV prevalence and diverse health
system capacities. However, while the number of tests
expanded rapidly, the public health impact was far from
optimal. In 3 of the 4 countries only 22% to 38% of
infants testing positive by PCR initiated ART. It is
important to recognize that the data reviewed covered a
period of time when international guidelines on when to
start treatment in infants were changing and therefore
not all infants were eligible for treatment at the time
they tested PCR positive. However, even after guidelines
had been changed, a substantial proportion of PCR-posi-
tive infants were still not being initiated on ART at the
review sites. The exception to this was Namibia which
has been able to achieve high population-based coverage
of both infant testing and treatment. Namibia’ss u c c e s s
demonstrates that it is feasible for EID services to con-
t r i b u t et oal a r g ep u b l i ch e a l t hi m p a c ti nah i g h l yr u r a l ,
low-income country. These observations underscore that
it is critical to focus more attention on ensuring that all
infants who test positive rapidly initiate ART.
In order to increase EID testing coverage, many coun-
tries have prioritized decentralizing the service both geo-
graphically and through various levels of the health
system. This review found that decentralization alone is
not sufficient to greatly increase utilization of services at
lower-level sites. To improve uptake of testing in the
first two months of life, infant follow up must be under-
scored in PMTCT counselling. With high coverage rates
in many countries for the first childhood vaccination,
HIV programs have been working to strengthen the
linkage between EPI (Expanded Programme on Immuni-
zations) to enable earlier EID. However these efforts can
only succeed when practical operational guidance on
provider initiated counselling is coupled with measures
Figure 4 Time of EID test stratified by age categories (2006-2009).
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Figure 5 Outcomes for HIV positive Infants at Reviewed Sites
in Uganda.
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health cards to enable the identification of infants need-
ing EID.
Among infants with PCR-positive results, very high
rates of loss to follow up occurred in the postnatal per-
iod. Many caregivers never received the EID results, and
very few sites reviewed had robust mechanisms in place
to follow up with infants whose parents or caregivers
did not return for results. Standard operating proce-
dures are needed by which sample collection and result
return are closely linked to counselling, clinical care,
and to follow up. It is critical for all sites to have a clear
understanding of the EID sample and result flow, the
patient flow, and who is responsible for key infant care
tasks.
In this regard, the reviews identified two broad types
of approaches to organization of EID services, each of
which potentially poses challenges for retaining infants.
In Senegal and Cambodia, the site laboratory technicians
manage the EID supplies, sample collection, record
keeping, dispatch of samples, and receipt of results.
Having skilled laboratory technicians can facilitate the
transportation of samples and communication with
referral laboratories, but not having clinical providers in
charge of coordinating the service can result in chal-
lenges with regard to post-test counselling, exposed
infant follow up, and returning the results to caregivers
and service providers. On the other hand, the model uti-
lized in Namibia and Uganda in which EID was offered
in multiple clinical units within a site (e.g. ART, MCH,
wards) requires significant site organization for consum-
ables and registers. With multiple collection points the
logistics of getting all samples to the referral laboratory
and all results to their correct collection point is
challenging.
In light of these difficulties, a third approach to the
organization of EID services may be useful in some
contexts, which includes aspects of both the centralized
and decentralized collection models. To address some of
the problems noted in the review, Uganda implemented
an EID strengthening pilot in which a single centralized
care location is designated where exposed infants receive
comprehensive longitudinal care (including CPT, infant
feeding counselling and support, ordering the EID tests,
returning the results, and follow-up until enrolment in
ART or discharge upon a final confirmed negative test.)
Sites pick the location of the EID care point themselves
by deciding which unit they believe is best positioned,
which may be ART, OPD, or MCH clinics - in most
cases sites have chosen ART clinics. HIV-exposed
infants presenting at other entry points are all referred
to and managed by this one designated care point. A
focal person is designated to be responsible for infant
follow-up at the EID care point, and monitoring tools,
job aids, and mentoring are provided for the care point
and referring units. Uganda has subsequently reported
strong improvements in the proportions of eligible
infants receiving test results and initiating ART at sites
that have implemented this approach [6], and based
upon this successful pilot is now scaling up this
approach nationally. While this has worked well in the
Ugandan setting, the optimal approach to organization
of services may vary in different settings depending on
factors such as health system capacity and HIV
prevalence.
Systematic referral mechanisms are also needed to
ensure PCR- positive infants are enrolled on ART. How-
ever, these were not present at most sites providing EID
services. Indeed, despite the co-location of testing and
HIV care and treatment in the same hospital (and some-
times the same unit), a high rate of attrition occurred
between testing and enrolment in HIV treatment for
those infants testing positi v eb yP C R .T h el i t t l ed a t a
available indicates that, even for the small number of
Figure 6 Initiation of Infants Testing PCR-positive on ART in Namibia. Data are from the 25 review sites in Namibia and represent the
proportion of known PCR-positive infants who were enrolled in HIV care services that initiated antiretroviral therapy <6 m after enrolling in care,
>6 m after enrolling, or not at all.
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substantial delays were common between when care-
givers received results and when infants were initiated
on treatment, with many PCR-positive infants being
enrolled in HIV care but never HIV treatment. Though
the reasons for delays and loss-to-follow-up between
enrolment in HIV care and enrolment on ART cannot
be determined from the current analysis, possible contri-
buting factors may be the requirement in some cases for
several adherence counselling visits prior to ART initia-
tion, the desire of clinicians to obtain a baseline CD4
prior to initiating ART, or the fact that some sites pro-
vide care for PCR-positive infants (mainly CPT and
infant feeding support) but have to out-refer to other
sites that offer ART. This data highlights the urgency of
streamlining current processes for initiating ART in
infants to avoid such delays which are resulting in
increased mortality in these highly vulnerable children.
Where feasible, decentralizing ART to lower-level clinics
that also provide MCH and EID may also have potential
to improve retention through enabling a “one stop
shop” where HIV treatment can be initiated without
referral to another site or hospital service.
There are several limitations to the conclusions that
can be drawn from this retrospective multi-country
review. Firstly, the data was routine programmatic data
and mostly cross-sectional. Estimating the proportion of
infants who were lost-to-follow-up at different points of
needed care in the postnatal period therefore required
the linking of data from several different sources of rou-
tinely-collected data because sites and national programs
do not follow HIV-exposed infants longitudinally. How-
ever significant efforts were made to eliminate repeat
PCR documentation to ensure no infants are double
counted. The possibility exists that some of the infants
that were estimated as lost-to-follow-up received ser-
vices, but that this was not recorded either because care
occurred at other sites that were not covered by the
review or because of the suboptimal quality of the routi-
nely collected data at the sites that were reviewed. We
also did not seek to collect data about care services pro-
vided to the HIV-positive mothers, such as whether they
were enrolled or retained in HIV care and treatment
services. Additionally, given the nature of the review, we
could not determine what the reasons were why infants
were lost-to-follow-up or if any specific approaches had
been used successfully to improve the continuum of
care. More in-depth prospective reviews would be help-
ful for programs to better understand these important
issues, and the optimal approaches to reduce loss-to-fol-
low-up and ensure timely ART initiation. Encouragingly,
since the reviews the countries involved have continued
to make improvements in their programs, including tak-
ing action to address the high rates of loss-to-follow-up.
Conclusion
This review provides useful insights into the function-
ing of EID services in low resource settings and gives
an indication of what changes are needed in order to
achieve optimal impact of this intervention. While the
volume of EID tests has expanded dramatically in
these four countries, a large proportion of HIV-
infected infants testing positive by PCR were not sub-
sequently initiated on treatment. In order to improve
retention and enable the achievement of high coverage
of paediatric treatment it is critical for EID services to
be fundamentally linked to PMTCT and MCH as well
as to ART programs. Shifting focus from the labora-
tory aspects of EID alone to the full package of HIV-
e x p o s e di n f a n tc a r es h o u l de n a b l eE I Ds e r v i c e st o
have a much greater impact on child survival in the
future.
Additional material
Additional file 1: EID Data Collector Tool. This is a copy of the
questionnaire used for the site-level data extraction. It covers the EID
continuum from early identification of the HIV exposed infant through to
discharge of the HIV negative baby with a confirmed status or initiation
on ART.
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